AI & ChatGPT searches , social queries for ANGIOKINASE INHIBITORS
Search references for ANGIOKINASE INHIBITORS. Phrases containing ANGIOKINASE INHIBITORS
See searches and references containing ANGIOKINASE INHIBITORS!
Search references for ANGIOKINASE INHIBITORS. Phrases containing ANGIOKINASE INHIBITORS
See searches and references containing ANGIOKINASE INHIBITORS!ANGIOKINASE INHIBITORS
Angiokinase inhibitors are a new therapeutic target for the management of cancer. They inhibit tumour angiogenesis, one of the key processes leading to
Angiokinase_inhibitors
Chemical compound
Meel JC, et al. (2004). "BIBF1120 a novel, small molecule triple angiokinase inhibitor: profiling as a clinical candidate for cancer therapy". European
Nintedanib
German pharmaceutical company
Alzheimer's. The company sold the rights to Faldaprevir, a HCV protease inhibitor to Trek Therapeutics. In July 2016, the company sold the commercialisation
Boehringer_Ingelheim
Fibrosis of lungs due to unknown causes
mild-to-moderate impairment in lung function". Nintedanib is a triple angiokinase inhibitor that targets receptor tyrosine kinases involved in the regulation
Idiopathic_pulmonary_fibrosis
Chemical compound
Company. It is an orally administered small molecule belonging to angiokinase inhibitor class which acts as an antagonist of VEGF receptors, platelet-derived
Motesanib
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS
ANGIOKINASE INHIBITORS